Int J Sports Med 2018; 39(09): 720-725
DOI: 10.1055/a-0633-9001
Clinical Sciences
© Georg Thieme Verlag KG Stuttgart · New York

Immune and Inflammatory Response in Atopic Elite Endurance Athletes

Renata Nakata Teixeira
1   Department of Physical Therapy, University of Sao Paulo, SP, Brazil
,
Gerson dos Santos Leite
1   Department of Physical Therapy, University of Sao Paulo, SP, Brazil
,
Renata Gorjao
2   Institute of Physical Activity Sciences and Sports, Post-Graduation Program in Human Movement Sciences, University Cruzeiro do Sul, Sao Paulo, Brazil
,
Patricia Palmeira
3   School of Medicine, University of S.o Paulo, Sao Paulo, Brazil
,
Cesar Miguel Momesso Santos
2   Institute of Physical Activity Sciences and Sports, Post-Graduation Program in Human Movement Sciences, University Cruzeiro do Sul, Sao Paulo, Brazil
,
Raquel Zambonatto
2   Institute of Physical Activity Sciences and Sports, Post-Graduation Program in Human Movement Sciences, University Cruzeiro do Sul, Sao Paulo, Brazil
,
Heloisa Helena de Oliveira
2   Institute of Physical Activity Sciences and Sports, Post-Graduation Program in Human Movement Sciences, University Cruzeiro do Sul, Sao Paulo, Brazil
,
Adriana Cristina Levada
2   Institute of Physical Activity Sciences and Sports, Post-Graduation Program in Human Movement Sciences, University Cruzeiro do Sul, Sao Paulo, Brazil
,
Iara Nely Fiks
4   Pulmonary Division, Heart Institute (InCor), University of S.o Paulo, Sao Paulo, Brazil
,
Celso Ricardo Fernandes Carvalho
1   Department of Physical Therapy, University of Sao Paulo, SP, Brazil
› Author Affiliations
Further Information

Publication History



accepted 15 May 2018

Publication Date:
25 June 2018 (online)

Abstract

The present study aimed to compare the immune and inflammatory responses between atopic (n=20) and non-atopic (n=39) elite endurance athletes. Fifty-nine elite runners and triathletes were assessed for the following measurements: Th1, Th2 and lymphocyte phenotyping and plasma levels of cortisol, chemokines, inflammatory cytokines and specific immunoglobulin E (IgE). Levels of salivary IgA, allergic symptoms and training data were also evaluated. No difference was observed in baseline lymphocyte levels. However, the Th1 lymphocytes of atopic athletes presented a lower response after activation. In contrast to this result, levels of salivary IgA and CXCL9 chemokine were higher in the atopic athletes. It was observed that the volume of training per week was linearly associated with Th1 levels, allergic symptoms and IgE levels. In addition, linear multiple regression analysis demonstrated that the volume of training was the only factor associated with allergic symptoms in atopic athletes (r=0.53; p=0.04). These results suggest that compared to non-atopic athletes, atopic athletes present a reduced Th1 response and higher levels of salivary IgA. Training volume is associated with the immune response and allergic symptoms, which suggests that they may play a role in the atopy in elite endurance athletes.

 
  • References

  • 1 American Thoracic Society and European Respiratory Society. ATS/ERS recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide, 2005. Am J Respir Crit Care Med 2005; 171: 912-930
  • 2 Bonini M, Braido F, Baiardini I, Del Giacco S, Gramiccioni C, Manara M, Tagliapietra G, Scardigno A, Sargentini V, Brozzi M, Rasi G, Bonini S. AQUA: Allergy Questionnaire for Athletes. Development and validation. Med Sci Sports Exerc 2009; 41: 1034-1041
  • 3 Bonini M, Gramiccioni C, Fioretti D, Ruckert B, Rinaldi M, Akdis C, Todaro A, Palange P, Carlsen KH, Pelliccia A, Rasi G, Bonini S. Asthma allergy and the Olympics: A 12-year survey in elite athletes. Curr Opin Allergy Clin Immunol 2015; 15: 184-192
  • 4 Bougault V, Turmel J, St-Laurent J, Bertrand M, Boulet LP. Asthma, airway inflammation and epithelial damage in swimmers and cold-air athletes. Eur Respir J 2009; 33: 740-746
  • 5 Boyum A. Isolation of leucocytes from human blood. A two-phase system for removal of red cells with methylcellulose as erythrocyte-aggregating agent. Scand J Clin Lab Invest Supp 1968; 97: 9-29
  • 6 Burney P, Malmberg E, Chinn S, Jarvis D, Luczynska C, Lai E. The distribution of total and specific serum IgE in the European Community Respiratory Health Survey. J Allergy Clin Immunol 1997; 99: 314-322
  • 7 Chiu SK, Collier CP, Clark AF, Wynn-Edwards KE. Salivary cortisol on ROCHE Elecsys immunoassay system: Pilot biological variation studies. Clin Biochem 2003; 36: 211-214
  • 8 Harriss DJ, Macsween A, Atkinson G. Standards for ethics in sport and exercise science research: 2018 update. Int J Sports Med 2017; 38: 1126-1131
  • 9 Helenius IJ, Tikkanen HO, Haahtela T. Occurrence of exercise-induced bronchospasm in elite runners: Dependence on atopy and exposure to cold air and pollen. Br J Sports Med 1998; 32: 125-129
  • 10 Johansson SG, Bieber T, Dahl R, Friedmann PS, Lanier BQ, Lockey RF, Motala C, Ortega Martell JA, Platts-Mills TA, Ring J, Thien F, Van Cauwenberge P, Williams HC. Revised nomenclature for allergy for global use: Report of the Nomenclature Review Committee of the World Allergy Organization. J Allergy Clin Immunol 2004; 113: 832-836
  • 11 Katz J, Michalek SM. Effect of immune T cells derived from mucosal or systemic tissue on host responses to Porphyromonas gingivalis. Oral Microbiol Immunol 1998; 13: 73-80
  • 12 Lancaster GI, Halson SL, Khan Q, Drysdale P, Wallace F, Jeukendrup AE, Drayson MT, Gleeson M. Effects of acute exhaustive exercise and chronic exercise training on type 1 and type 2 T lymphocytes. Exerc Immunol Rev 2004; 10: 91-106
  • 13 Marshall A, Celentano A, Cirillo N, McCullough M, Porter S. Tissue-specific regulation of CXCL9/10/11 chemokines in keratinocytes: Implications for oral inflammatory disease. PLoS One 2017; 12: 1-17
  • 14 Medoff BD, Sauty A, Tager AM, Maclean JA, Smith RN, Mathew A, Dufour JH, Luster AD. IFN-gamma-inducible protein 10 (CXCL10) contributes to airway hyperreactivity and airway inflammation in a mouse model of asthma. J Immunol 2002; 168: 5278-5286
  • 15 Mega J, McGhee JR, Kiyono H. Characterization of cytokine producing T cells, TCR expression, and IgA plasma cells in salivary gland-associated tissues. Adv Exp Med Biol 1995; 371B: 1103-1108
  • 16 Nagao AT, Ramos OL, Pereira AB. Immunoassays of secretory IgA and secretory component. Braz J Med Biol Res 1990; 23: 211-224
  • 17 O'Connell EJ. The burden of atopy and asthma in children. Allergy 2004; 59: 7-11
  • 18 Oboki K, Ohno T, Saito H, Nakae S. Th17 and allergy. Allergol Int. 2008; 57: 121-134
  • 19 Price OJ, Hull JH, Backer V, Hostrup M, Ansley L. The impact of exercise-induced bronchoconstriction on athletic performance: A systematic review. Sports Med 2014; 44: 1749-1761
  • 20 Romagnani S. Regulation of the T cell response. Clin Exp Allergy 2006; 36: 1357-1366
  • 21 Shaw DM, Merien F, Braakhuis A, Dulson D. T-cells and their cytokine production: The anti-inflammatory and immunosuppressive effects of strenuous exercise. Cytokine 2018; 104: 136-142
  • 22 Silva D, Moreira A. The role of sports and exercise in allergic disease: Drawbacks and benefits. Expert Rev Clin Immunol 2015; 11: 993-1003
  • 23 Steensberg A, Fischer CP, Keller C, Møller K, Pedersen BK. IL-6 enhances plasma IL-1ra, IL-10, and cortisol in humans. Am J Physiol Endocrinol Metab 2003; 285: E433-E437
  • 24 Suzuki K, Nakaji S, Kurakake S, Totsuka M, Sato K, Kuriyama T, Fujimoto H, Shibusawa K, Machida K, Sugawara K. Exhaustive exercise and type-1/type-2 cytokine balance with special focus on interleukin-12 p40/p70. Exerc Immunol Rev 2003; 9: 48-57
  • 25 Swann C, Moran A, Piggott D. Defining elite athletes: Issues in the study of expert performance in sport psychology. Psychol Sport Exerc 2015; 16: 3-14
  • 26 Teixeira RN, Mendes FA, Martins MA, Mickleborough TD, Carvalho CR. AQUA© as predictor of allergy in elite marathon runners. World Allergy Organ J 2014; 7: 7
  • 27 Thomsen SF. Epidemiology and natural history of atopic diseases. Eur Clin Respir J 2015; 24: 1-6
  • 28 Van Raemdonck K, Van den Steen PE, Liekens S, Van Damme J, Struyf S. CXCR3 ligands in disease and therapy. Cytokine Growth Factor Rev 2015; 26: 311-327
  • 29 Walsh NP, Gleeson M, Shephard RJ, Gleeson M, Woods JA, Bishop NC, Fleshner M, Green C, Pedersen BK, Hoffman-Goetz L, Rogers CJ, Northoff H, Abbasi A, Simon P. Position statement. Part one: Immune function and exercise. Exerc Immunol Rev 2011; 17: 6-63
  • 30 World Health Organization. White Book on Allergy 2011–2012 Executive Summary. Prof. Ruby Pawankar, MD, PhD; Prof. Giorgio Walkter Canonica, MD; Prof. Stephen T. Holgate, BSc, MD, DSc, FMed Sci; and Prof. Richard F. Lockey, MD; eds